Common Stock, Shares, Outstanding of BIOCRYST PHARMACEUTICALS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BIOCRYST PHARMACEUTICALS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • BIOCRYST PHARMACEUTICALS INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 213,060,000, a 2.2% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BIOCRYST PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 213,060,000 +4,517,000 +2.2% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 210,522,000 +3,403,000 +1.6% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 209,905,000 +3,276,000 +1.6% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 209,208,000 +2,861,000 +1.4% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 208,543,000 +2,772,000 +1.3% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 207,119,000 +17,316,000 +9.1% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 206,629,000 +17,138,000 +9% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 206,347,000 +17,464,000 +9.2% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 205,771,000 +17,865,000 +9.5% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 189,803,000 +3,392,000 +1.8% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 189,491,000 +3,615,000 +1.9% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 188,883,000 +3,311,000 +1.8% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 187,906,000 +3,556,000 +1.9% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 186,411,000 +6,620,000 +3.7% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 185,876,000 +7,151,000 +4% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 185,572,000 +7,902,000 +4.4% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 184,350,000 +7,467,000 +4.2% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 179,791,000 +3,225,000 +1.8% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 178,725,000 +2,296,000 +1.3% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 177,670,000 +23,478,000 +15% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 176,883,000 +22,801,000 +15% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 176,566,000 +66,128,000 +60% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 176,429,000 +66,059,000 +60% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 154,192,000 +43,922,000 +40% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 154,082,000 +44,019,000 +40% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 110,438,000 +813,000 +0.74% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 110,370,000 +11,442,000 +12% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 110,270,000 +11,568,000 +12% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 110,063,000 +11,652,000 +12% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 109,625,000 +11,236,000 +11% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 98,928,000 +18,500,000 +23% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 98,702,000 +18,321,000 +23% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 98,411,000 +24,629,000 +33% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q3 2017 98,389,000 +24,631,000 +33% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 80,428,000 +6,727,000 +9.1% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 80,381,000 +6,688,000 +9.1% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 73,782,000 +427,000 +0.58% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 73,758,000 +421,000 +0.57% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 73,701,000 +533,000 +0.73% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 73,693,000 +1,219,000 +1.7% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 73,355,000 +1,400,000 +1.9% 31 Dec 2015 10-K 27 Feb 2017 2016 FY
Q3 2015 73,337,000 +1,476,000 +2.1% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 73,168,000 +1,450,000 +2% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 72,474,000 +12,409,000 +21% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 71,955,000 +12,863,000 +22% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q3 2014 71,861,000 +12,770,000 +22% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 71,718,000 +17,521,000 +32% 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 60,065,000 +8,660,000 +17% 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q4 2013 59,092,000 +8,199,000 +16% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 59,091,000 +8,211,000 +16% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 54,197,000 +4,068,000 +8.1% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 51,405,000 +2,250,000 +4.6% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 50,893,000 +5,231,000 +11% 31 Dec 2012 10-K 10 Mar 2014 2013 FY
Q3 2012 50,880,000 +50,834,805 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 50,129,000 +50,083,850 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 49,155,000 31 Mar 2012 10-Q 08 May 2012 2012 Q1
Q4 2011 45,662,000 +703,000 +1.6% 31 Dec 2011 10-K 11 Mar 2013 2012 FY
Q3 2011 45,195* 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 45,150* 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q4 2010 44,959,000 31 Dec 2010 10-K 06 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.